Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary

Champions Oncology

21/07/2022 22:41

* Champions Oncology Inc  CSBR.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in April. The
mean expectation of three analysts for the quarter was
for earnings of 3 cents per share.
    * Revenue rose 21.9% to $12.88 million from a year ago; 
analysts
expected $12.72 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 3 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Champions Oncology Inc shares had risen by 4.1% this
quarter and
lost 0.4% so far this year.
    * The company reported a quarterly loss of $344 thousand.
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated July 21 at 09:41 p.m.  ​All
figures in US dollars unless otherwise stated.
 QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Apr. 30 2022      0.03           -0.03          Missed
 Jan. 31 2022      0.03           0.05           Beat
 Oct. 31 2021      0.01           0.02           Beat
 Jul. 31 2021      0.01           -0.01          Missed
 This summary was machine generated from Refinitiv data July 21
at 09:41 p.m